menu
    • menu

    Company profile for TRIANA Biomedicines

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Triana Biomedicines is focused on developing “molecular glues” to treat diseases by targeting and eliminating disease-causing proteins, especially in oncology. Using proprietary technology, Triana identifies small molecules that promote interactions between proteins, activating natural cellular processes to degrade harmful proteins. This approach allows the targeting of disease-causing proteins previously considered undrug...
    Triana Biomedicines is focused on developing “molecular glues” to treat diseases by targeting and eliminating disease-causing proteins, especially in oncology. Using proprietary technology, Triana identifies small molecules that promote interactions between proteins, activating natural cellular processes to degrade harmful proteins. This approach allows the targeting of disease-causing proteins previously considered undruggable, offering novel treatment pathways. The company's innovative research aims to transform drug discovery and address unmet medical needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TRIANA BiomedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1050 Waltham Street, Suite 301 Lexington, MA 02421
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://trianabio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TRIANA Biomedicines Presents TRI-611 Orally At AACR 2026
    TRIANA Biomedicines Presents TRI-611 Orally At AACR 2026

    15 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-15/triana-biomedicines-announces-oral-presentation-of-tri-611-and-additional-poster-presentations-at-th

    PHARMIWEB
    15 Apr 2026
    Share Share
    FDA Fast-Track Designation TRIANA's TRI-611 for ALK+ NSCLC Cancer
    FDA Fast-Track Designation TRIANA's TRI-611 for ALK+ NSCLC Cancer

    25 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-25/triana-biomedicines-tri-611-granted-us-fda-fast-track-designation-for-treatment-of-alk-positive-n

    PHARMIWEB
    25 Mar 2026
    Share Share
    TRIANA Doses First Patient In TRI-611 Ph1/2 NSCLC Trial
    TRIANA Doses First Patient In TRI-611 Ph1/2 NSCLC Trial

    19 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-19/triana-biomedicines-announces-first-patient-dosed-in-a-phase-12-trial-evaluating-tri-611-for-the-tr

    PHARMIWEB
    19 Mar 2026
    Share Share
    TRIANA Biomedicines Raises 120M to Advance Glue Degrader Platform
    TRIANA Biomedicines Raises 120M to Advance Glue Degrader Platform

    03 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-03/triana-biomedicines-announces-oversubscribed-120m-series-b-financing-to-advance-its-molecular-glue

    PHARMIWEB
    03 Dec 2025
    Share Share
    Triana Biomedicines Appoints Caroline Germa as CMO
    Triana Biomedicines Appoints Caroline Germa as CMO

    07 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/triana-biomedicines-announces-the-appointment-of-caroline-germa-as-ch-1024578

    ACCESSWIRE
    07 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search